Library
1004venturepartners.comCrawled Oct 25, 2026
Product
6 pages- Deka Bioscience/1004vpspv/deka
Deka Biosciences develops targeted immunocytokines called Diakines for oncology and inflammatory diseases, including DK210 for solid tumors and DK410 for Crohn’s disease.
- Investment fund I/fund1
- Portfolio/portfolio-1
- Sinaptica therapeutics/1004vpspv/sinaptica
Sinaptica is a pioneering neurotechnology company dedicated to advancing brain health and cognitive longevity through deep tech innovation. Positioned at the intersection of neuroscience, artificial intelligence, and healthcare infrastructure, Sinaptica develops scalable solutions that enhance neural performance and mitigate age-related cognitive decline. The company’s mission aligns with the broader Healthy Aging movement by delivering data-driven, personalized interventions designed to extend
Blog
5 pages- Blog 3/ageless-insights
- Blog Post Title Four/ageless-insights/blog-post-title-four-agwbx
- Blog Post Title One/ageless-insights/blog-post-title-one-sn3ee
- Blog Post Title Three/ageless-insights/blog-post-title-three-2l538
Team
3 pages- Team/team
Soyoung is a visionary leader who aims to keep people healthy through transformative longevity technologies and healthcare infrastructures.
- Team 1/team-1
Dr. Benjamin Larson joined in 2025 following the successful exit of his Silicon Valley biotech startup. Dr. Larson spent nine years as a Research Scientist and PI at Harvard and MIT in the laboratory of Robert Langer, where he led a research group specializing in regenerative medicine, cell therapy, and drug delivery. A prolific innovator, his career includes over 20 patents and papers with an h-index of 19 and more than 8,200 citations. As a startup guru, he has had operating experience in 7 bi
- Team 1 2/team-1-2
Min Bang serves as a Venture Analyst Intern at 1004 Venture Partners, focusing on healthcare and technologies for aging populations. He previously led pharmacy operations at U.S. Air Force hospitals, Sutter Health, and UCSF Health.
About
2 pages- About/about-1
1004 Venture Partners was founded to improve healthcare for aging populations by investing in startups using AI, advanced therapeutics, and medical technologies.
- About (old)/about
Contact
3 pages- Accredited Investor Questionnaire/1004vp-questionnaire
- Pitch/pitch-1
- Pitch (old)/pitch
1004 Venture Partners responds to inquiries about investment opportunities, limited partnerships, and collaboration proposals.
Homepage
2 pagesPrivacy
2 pages- Online Privacy Policy/online-privacy-policy
- Privacy Policy/privacy-policy
Terms & Conditions
2 pages- Legal/legal
1004 Venture Partners is a global venture capital fund investing in health tech, age tech, and healthcare infrastructure for healthy aging.
- Terms of Use/terms-of-use
